Syndax Pharmaceuticals (SNDX) EBITDA Margin Growth (3y) (2018 - 2024)
Syndax Pharmaceuticals (SNDX) EBITDA Margin Growth (3y) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -133,040.00 |
| Sep 30, 2024 | -55,474.00 |
| Jun 30, 2024 | 377,242.00 |
| Dec 31, 2021 | 516,328.00 |
| Sep 30, 2021 | 454,551.00 |
| Jun 30, 2021 | -89,261.00 |
| Mar 31, 2021 | -195,567.00 |
| Dec 31, 2020 | -359,270.00 |
| Sep 30, 2020 | -17,400.00 |
| Jun 30, 2020 | 15,577.00 |
| Mar 31, 2020 | 33,616.00 |
| Dec 31, 2019 | -8,537.00 |
| Sep 30, 2019 | 152,667.00 |
| Jun 30, 2019 | -122,564.00 |
| Mar 31, 2019 | -103,808.00 |
| Dec 31, 2018 | -355,353.00 |
| Sep 30, 2018 | -278,673.00 |
| Jun 30, 2018 | 2.76 Mn |